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Association between
Air Pollution and Adverse
Pregnancy Outcomes in
Vancouver
In the November 2003 issue of EHP, Liu
et al. (2003) concluded that “relatively low
concentrations of gaseous air pollutants are
associated with adverse effects on birth out-
comes.” Although this may be true from a
purely statistical sense, there appear to be
limitations of this research that suggest
cautious interpretation of the findings. 
Liu et al. (2003) evaluated individual-
level birth certificate data, which is an
improvement over the ecologic designs of
past time-series studies on pollution.
However, birth records do not contain most
of the variables that are important predictors
of low weight and preterm births. These
include smoking, alcohol and/or drug abuse,
low socioeconomic status (SES), small
maternal weight or height, complications of
the current or previous pregnancy [e.g.,
pregnancy-induced hypertension, previous
low birth weight (LBW), spontaneous abor-
tion], insufficient weight gain during preg-
nancy, maternal illness (e.g., fever), and
job-related exertion (Berkowitz and
Papiernik 1993; Holmes and Soothill 1996;
Kramer 1987, 2003; Lang et al. 1996;
Moore 2003). Many of these are major fac-
tors that substantially affect risk. For exam-
ple, maternal smoking during pregnancy,
which has a prevalence of 10–20% in the
United States (Ebrahim et al. 2000;
O’Campo et al. 1995), is associated with a
2- to 4-fold increase in risk of LBW or
growth restriction (Kramer 1987; Lang et al.
1996; Nordentoft et al. 1996). Therefore,
there is considerable room for uncontrolled
confounding that might account for the
small odds ratio of 1.05–1.10 observed by
Liu et al. (2003).
Liu et al. (2003) argued that uncon-
trolled or residual confounding is an
unlikely explanation for their results
because a) there is no evidence that these
factors are associated with air pollution;
b) ecologic measures of SES did not modify
the associations; and c) “there were only
slight differences between crude and
adjusted estimates,” and “individual charac-
teristics ... did not attenuate the risk esti-
mates.” However, these arguments have
limitations. 
First, there may not be evidence that
important risk factors co-vary with pollu-
tion, but it seems reasonable that many
might correlate with residential location.
Liu et al. (2003) linked pollution measure-
ments in 13 census subdivisions to births
within those subdivisions. If gaseous pollu-
tant measurements and other factors (e.g.,
SES, smoking prevalence) co-vary by census
subdivision, then confounding could occur.
Second, ecologic measures are poor surro-
gates for individual-level ones, which can
result in confounder misspecification and
residual confounding (Greenland 1980; Liu
1988; Marshall and Hastrup 1996;
Morgenstern 1998). Third, the individual-
level covariates included in some of the
models did appear to have substantive
impacts. For example, the odds ratio for the
association between LBW and first-month
sulfur dioxide exposure changed from a
crude value of 0.95 to a significant 1.11
after adjustment for confounding. This is a
17% absolute increase in risk and a change
in coefficient from –0.05 to +0.10 per
5 ppb. In other instances the adjustment
caused a significant elevation to become a
deficit (e.g., association between preterm
birth and first-month exposure to ozone) or
a null value to become a significant protec-
tive effect (preterm birth and last-month
ozone exposure). This apparent impact of
confounding was caused by variables (e.g.,
maternal age and season of birth) that are
weaker risk factors than many missing vari-
ables, such as smoking, SES, and weight
gain (Berkowitz and Papiernik 1993;
Kramer 1987; Lang et al. 1996). This sug-
gests considerable potential for residual
confounding. 
The findings of Liu et al. (2003) also
lack biological coherence with the literature.
The authors invoked a biological mecha-
nism for air pollution similar to cigarette
smoking. For smoking, the risk is predomi-
nantly during the third trimester, primarily
from decreased fetal growth, which has been
attributed to decreased maternal and fetal
nutrition among smokers and hypoxia from
inhaled carbon monoxide (Holmes and
Soothill 1996; Kramer 1987; Petridou et al.
1990). However, most of the significant
increases reported by Liu et al. (2003) were
associated with exposures during the first
month or trimester, with no effects seen
during the third trimester. It is unclear how
these early, low-level pollution exposures,
which lack the substantive impact of smok-
ing, would alter fetal growth. 
Liu et al. (2003) also do not discuss the
potential for spurious results due to multi-
ple comparisons. The authors reported
36 associations within the tables, and many
more were likely performed, including
multipollutant models. Therefore, at least
some of the significant results may be due
to chance.
In conclusion, the above limitations
could easily account for the findings reported
by Liu et al. (2003), without invoking novel
effects from air pollution.
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Air Pollution and Adverse
Pregnancy Outcomes: Response
We thank Bukowski for his critical comments
on our article (Liu et al. 2003), in which we
reported associations between ambient air
pollution and adverse pregnancy outcomes in
Vancouver, Canada. In recent years, air pollu-
tion has come to be recognized as an impor-
tant risk factor for a number of adverse health
outcomes, particularly cardiorespiratory mor-
bidity (Burnett et al. 1997, 2001; Lin et al.
2002, 2003; Yang et al. 2003) and mortality
(Burnett et al. 1997; Dockery et al. 1993;
Pope et al. 1995; Villeneuve et al. 2003).
The adverse effects of air pollution on
pregnancy outcomes, such as low birth
weight (LBW), preterm birth, intrauterine
growth retardation (IUGR), and develop-
mental anomalies are of increasing concern.
Before our study, there were reports of asso-
ciations between particulate (total suspended
particulate) and gaseous (carbon monoxide,
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lutants and adverse pregnancy outcomes
from southern California (Ritz et al. 2000,
2002), China (Wang et al. 1997; Xu et al.
1995), and the Czech Republic (Bobak
2000; Dejmek et al. 1999). Replication of
these findings in different populations under
different conditions of exposure is an impor-
tant aspect of epidemiologic research, with
consistency of results strengthening the
weight of evidence for a true association
between exposure and outcome.
Data on important predictors of adverse
pregnancy outcomes were not available to us
for use in our study (Liu et al. 2003).
Although numerous risk factors have been
identified (including maternal age, parity,
infant sex, and season of birth, as well as ges-
tational age and birth weight, in the case of
LBW and preterm birth, respectively, which
we were able to take into account), our
understanding of the etiology of adverse preg-
nancy outcomes remains far from sufficient
(Kramer 2003). The omission of known or
unknown risk factors for birth anomalies may
lead to uncontrolled or residual confounding
of the association between air pollution and
adverse pregnancy outcomes, as Bukowski
suggests. However, the extent to which resid-
ual confounding might occur in our data is
unclear. Schwartz and Morris (1995) have
argued that the estimated effects of air pollu-
tion are unlikely to be confounded by these
factors because they are unlikely to be corre-
lated with daily air pollution levels.
Exposure assessment is always a critical
factor in environmental epidemiology
(Rothman 1993). Like most other studies
of air pollution and population health, our
study (Liu et al. 2003) relied on ecologic
rather than personal indicators of exposure,
with average ambient air pollution concen-
trations determined using one or more fixed
site monitors within census areas in
Vancouver. Janssen et al. (1998, 1999) have
suggested that air pollution levels from out-
door monitoring stations can provide useful
surrogates for personal exposure. Exposure
misclassification due to the use of fixed site
ambient monitors rather than personal
dosimeters is likely to underestimate rather
than overestimate the effect of air pollution
on birth outcomes (Mallick et al. 2002;
Zeger et al. 2000).
The weight of evidence that air pollu-
tion is causally related to adverse pregnancy
outcomes would be considerably increased
through understanding of biological mecha-
nisms by which such effects could occur. 
Burkowski notes that we (Liu et al.
2003) included a number of statistical tests
of the strength of association between air
pollution and adverse pregnancy outcomes,
and observes that multiple testing raises the
risk of false positives. Our a priori strategy
for hypothesis testing focused on predeter-
mined stages of pregnancy (month or
trimester), which are thought to represent
periods of differential susceptibility to
exogenous exposures. Findings from both
epidemiologic and toxicologic studies sug-
gest that the fetus is most susceptible to the
effects of air pollution during the first
trimester (Generoso et al. 1987; Rutledge
2000). Human studies also have suggested
that initial changes leading to IUGR might
be triggered in early pregnancy, around the
time of implantation (Duvekot et al. 1995;
Khong et al. 1986). Air pollutants may be
absorbed into the maternal bloodstream,
cross the placental barrier, and have direct
toxic effects on the fetus.
Our a priori strategy for the develop-
ment of appropriate risk models focused on
single-pollutant models, with adjustment
for relevant covariates available to us, as we
reported in Tables 4–7 (Liu et al. 2003).
Our strategy also called for an assessment of
the robustness of the associations between
pregnancy outcomes and specific pollutants
against adjustment for copollutants.
Although this strategy does involve a mod-
erately large number of statistical tests of
the significance of logistic regression coeffi-
cients associated with specific pollutants,
our evaluation of the data is based more on
the evidence provided by this set of hypoth-
esis tests as a whole, rather than on the
results of individual tests alone.
Overall, our data suggest that adverse
pregnancy outcomes are associated with
exposures to air pollutants during pregnancy,
particularly in early gestation. Because of
limitations of our study, we (Liu et al. 2003)
concluded that 
“these effects require further examination in other
populations, and further research also needs to be
conducted with more detailed information on
personal exposures, effect modifiers, and other
adverse pregnancy outcomes such as birth defects
and spontaneous abortion.” 
Our data need to be interpreted in the con-
text of the emerging body of scientific evi-
dence on air pollution and adverse pregnancy
outcomes, to which we have made a contri-
bution.
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Bhopal: No Silver Linings
I read with interest the article “Lessons
Learned? Chemical Plant Safety since
Bhopal,” by Ernie Hood (2004). I would
recommend it to all interested in safety in
chemical plants or safety in other fields.
As mentioned in the article (Hood 2004),
this year is the 20th anniversary of the Bhopal
tragedy. An international conference on the
20th anniversary of the tragedy, Bhopal and
Its Effects on Process Safety, will be held
1–3 December 2004 at the Indian Institute
of Technology in Kanpur, India, with a visit
to the Bhopal plant planned on 4 December
for those who are interested; details are avail-
able online (http://www.iitk.ac.in/infocell/
announce/bhopal). Although the deadline for
abstracts has passed, we will still consider out-
standing papers. 
I would also like to comment on the leg-
end for the figure on page A354 of Hood’s
article (Hood 2004): “A toxic cloud’s silver
lining?” The question mark does indicate
that there are some doubts whether the
death of many thousands and the continued
suffering of a still larger number should be
considered to have a silver lining. In pre-
dictable accidents, the large number of
deaths produce only untold suffering and
not proportionate advantages to the society.
The earlier leakages at the Union Carbide
Bhopal plant were well known and docu-
mented in the newspapers, but neither the
company nor the government took enough
actions to save the city from the expected
accident. According to Charles Perrow of
Yale University (Perrow 1999), this is one
accident that could not have been worse,
contrasting the common cliche “we were
lucky it wasn’t worse,” which is used to
describe many other accidents and deliberate
actions, such as the 9/11 attacks on the
World Trade Center (WTC) in New York
City. If the explosions in the WTC had
taken place later in the day, many more peo-
ple would have been inside the two towers
and many more would have died. No one
should say the deaths at the WTC and the
Pentagon provide a silver lining to the war
against terrorism. Terrorist acts were already
being conducted in several places in Asia,
Spain, Northern Ireland, Latin America, and
other locations, except the world as a whole
decided to look the other way and let indi-
vidual countries respond. Similarly, because
the problems caused by fascism were known
or could be foreseen, World War II did not
have to happen and cause many millions of
deaths. The Allies recently observed the
60th anniversary of the D-Day invasions of
several beaches in France; so many deaths
and much misery was not necessary for us to
understand what fascism could do.
Therefore, I hope that people would
reconsider their comments of silver linings
on others’ sufferings. The use of the question
mark indicates that Hood (2004) was not
sure of this, and I commend that hesitant
punctuation mark.
The author declares he has no competing finan-
cial interests.
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Editor’s note: The caption referred to by
Gupta was written by me, not the author of
the article, and I take full responsibility for it.
In no way did I intend to trivialize the
tragedy at Bhopal. I wanted to make the point
that sometimes beneficial lessons may be
learned from tragic situations, but my attempt
to be “clever” was unfortunate. I regret my
choice of wording and that it caused offense.
Kimberly Thigpen Tart
News Editor, EHP
E-mail: thigpenk@niehs.nih.gov
Study on Failures to Disclose
Conflicts of Interest in
Environmental Health
Perspectives
The Center for Science in the Public
Interest (CSPI) recently investigated con-
flict of interest disclosures in a cross-section
of leading scientific and medical journals,
including EHP, to determine adherence to
their own policies.
EHP’s conflict of interest disclosure
policy (EHP 2003) outlines a comprehensive
list of “competing financial interests” that
an author must disclose along with a pub-
lished article. They include “grant support,
employment (recent, present, or antici-
pated), … travel, consultancies, advisory
board positions, patent and royalty arrange-
ments, stock shares, … and the like.” It
limits disclosure to situations where an
author “may gain or lose financially
through publication.” The editors also
eschew any effort at enforcement, relying
instead on the veracity of authors. EHP
encourages its readers to scrutinize disclosure
statements and offers to publish letters that
address alleged inaccuracies.
During the study period of December
2003 through February 2004, EHP pub-
lished 37 scientific studies. Only 2 of the
studies indicated they were funded by
industry, and only these 2 studies included
conflict of interest disclosure statements for
at least some of the authors.
The CSPI investigated the first and last
authors involved in the 35 studies who did
not disclose conflicts of interest. Our inves-
tigation revealed at least 3 articles (8.6%)
where either the first or last authors should
have disclosed conflicts in accordance with
the disclosure policy. 
First, a Procter and Gamble (P&G)
scientist, William Owens, was identified only
as a representative of the Organisation for
Economic Co-operation and Development.
The article (Yamasaki et al. 2003) validated
an assay that may be used on P&G products.
Owens did not disclose his corporate affilia-
tion in this article, despite having disclosed
his P&G employment in a previous EHP
article (Owens and Köeter 2003).
Second, a Quebec, Canada, group led by
Pierre Ayotte of CHUQ-Laval University
Medical Center studied the effects of
organochlorines and methyl mercury on a
remote coastal population (Bilrha et al.
2003). Although there was no disclosure of
a conflict of interest, the study was funded
in part by the Canadian Network of
Toxicology Centers, which is funded in part
by the Canadian Chemical Producer
Association, an industry trade group. Several
of Ayotte’s previous studies were funded in
part by the Canadian Chemical Producer
Association and the Canadian Chlorine
Coordinating Committee, although Ayotte
was not directly compensated for this work.
The third group of authors who did not
disclose conflicts of interest are scientists at
Macquarie University who investigated the
sources of lead in children near a zinc–lead
smelter (Gulson et al. 2004). Brian Gulson,
a professor in Macquarie’s graduate school
of the environment, did not disclose that he
is listed as an adviser on the website of a
consulting group that advised Pasminco
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Services Pty Ltd. 2003), the company that
ran the smelter. In a subsequent e-mail com-
munication, Gulson informed the CSPI that
one of his coauthors, Karen Mizon, was the
wife of the owner of the consulting group.
In each of those cases, at least one of the
authors of a study may gain financially from
publication of the article, thus meeting the
test of the EHP policy. Owens was directly
employed by a company that might be
affected by his findings. Gulson’s colleagues
stood to gain financially from a company
directly affected by the subject matter of
their articles. 
Ayotte’s study, although a borderline
case, should have contained a disclosure
statement because he had collaborated on
industry-funded studies in the past and the
study in question was funded by an industry-
supported group. When a field of research is
so closely tied to an industry, future funding
for research may involve the goodwill of that
industry. The spirit of conflict of interest
disclosure is best served by full disclosure in
such cases.
A fourth case of nondisclosure was not
included in our results. In February 2004,
EHP published a study funded by the
National Institutes of Health that claimed
polychlorinated biphenyls (PCBs) inhibit a
receptor involved in clearing foreign sub-
stances from humans (Tabb et al. 2004).
One of the authors, Bruce Blumberg, of the
Department of Developmental and Cell
Biology at the University of California,
Irvine, is listed as a co-inventor on a patent
granted in 2002 on the gene for an unre-
lated receptor in frogs. The use claimed for
the frog gene is that it may be useful in
identifying compounds that affect the
receptor. 
Should Blumberg disclose that patent as
a potential conflict of interest? In an e-mail
communication, he defended his failure to
disclose by asking, “Do you seriously
believe that a patent for a Xenopus (frog)
nuclear receptor has any bearing on a paper
about a mammalian receptor with an
entirely different function?” Strict conflict
of interest policies would argue “yes,”
because it is impossible to predict how the
information in the new study will affect the
use of previous knowledge or what inven-
tions considered irrelevant today may be
extremely useful (and lucrative) in the
future. Even though EHP’s policy (EHP
2003) says “may gain,” we did not count
his nondisclosure in our statistics.
Judging from the findings of our limited
survey, a significant percentage of articles
published in EHP (8.6%) fail to disclose rel-
evant conflicts of interest of authors. We
cannot determine whether authors are not
disclosing the relevant information to EHP,
or if they are providing the information but
EHP is not publishing the disclosures.
Considering the importance of providing
readers with such information, it would
seem that EHP needs to develop mecha-
nisms to minimize failures to provide “full
disclosure of competing financial interests”
(EHP 2003). One possible mechanism for
improving compliance would be for EHP
not to accept for 3 years any papers submit-
ted by authors who failed to disclose infor-
mation about conflicts of interest.
I look forward to your response.
The author is employed as the director of the
Integrity in Science Project at the Center for
Science in the Public Interest. 
Merrill Goozner
Integrity in Science Project
Center for Science in the Public Interest
Washington, DC
E-mail: mgoozner@cspinet.org
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Conflicts of Interest: 
Owens’ Response
To clarify comments from Goozner and the
Center for Science in the Public Interest
(CSPI), I would like to provide the perti-
nent facts on my compliance with EHP’s
policy on competing financial interest dis-
closure. 
First, I was on loan or “seconded” from
Procter & Gamble (P&G) to the Organisa-
tion for Economic Co-operation and
Development (OECD) in Paris. The second-
ment was arranged at the request of the
OECD, and I was officially under contract
and employed by them from October 2002
through October 2003. I offer the former
manager of the department, Herman Köeter;
the current manager, Andrew Wagner; and
their manager, Robert Visser, as references
for these points.
Second, in this approximate period, I was
a corresponding or contributing author on
11 relevant publications on assays that were
either undergoing formal validation at the
OECD or were being developed along simi-
lar lines for endocrine mechanisms (Ashby
et al. 2002a, 2002b, 2003, 2004; Fang et al.
2003; Kanno et al. 2001, 2003a, 2003b;
Owens and Ashby 2002; Owens and Köeter
2003; Owens et al. 2003; Yamasaki et al.
2003). In all cases but one, my P&G address
was used.
Third, the one exception involved the
article questioned by Goozner (Yamasaki
et al. 2003). Kanji Yamasaki of the Chemical
Evaluation and Research Institute in Japan
was the corresponding author in this case.
Because work on this manuscript (Yamasaki
et al. 2003) occurred while I was at the
OECD, Yamasaki used the OECD affilia-
tion when submitting the manuscript to
EHP. I simply did not notice the affiliation.
If I had, I would have changed it to use my
P&G affiliation to be consistent with the
other 10 publications during this period.
Last, neither I nor P&G have any finan-
cial interest in the publications or their sub-
ject matter. Rather, this work was done to
progress both development and validation
work on safety tests that have potential for
use to serve a diverse range of parties,
including regulators, industry, and the pub-
lic. Therefore, I do not see how allegations
of a competing financial interest are valid in
this case, even considering the oversight on
the affiliation.
I hope this fully clarifies the record on this
matter and lays the CSPI allegations to rest.
The author is employed by The Procter and
Gamble Company.
J. William Owens
The Procter and Gamble Company
Central Product Safety
Cincinnati, Ohio
E-mail: owens.jw@pg.com
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Conflicts of Interest: 
Ayotte’s Response
Goozner contacted me by e-mail on 24 June
2004, and I promptly, honestly, and to the
best of my knowledge answered questions
regarding his claim that I did not disclose a
conflict of interest while publishing our arti-
cle (Bilrha et al. 2003) in EHP. Although I
thought I made it clear that he was wrong in
his allegations, he nevertheless chose to go
ahead and include my name in a report pub-
lished on the Center for Science in the
Public Interest’s (CSPI) website (CSPI 2004)
and in his letter to EHP. Here are the facts. 
In our 2003 manuscript (Bilrha et al.
2003), we acknowledged funding from the
Canadian Network of Toxicology Centers
(CNTC). As the corresponding author, I
read the conflict of interest statement and
indicated that I had nothing to declare, nei-
ther for me nor for the coauthors. I did not
know at that time that the Canadian
Chemical Producer Association was partly
funding the CNTC. On their website
(CNTC 2004), the CNTC indicates being
funded mostly by public sources (90%) and
does not mention the identity of private
sources. In any case, had I known this at the
time of publication, it would not have
changed anything, because I never personally
received any funds (or compensation of any
sort, or stood to gain financially) from the
Canadian Chemical Producer Association or
the Canadian Chlorine Coordinating
Committee. Goozner is wrong when he
mentions that several of my previous studies
were funded by these interest groups. I was a
coauthor on two articles published previ-
ously in EHP, in which funding from these
interest groups was acknowledged, along
with other sources of funding (Sandau et al.
2000, 2002). I collaborated in the work, but
I was not the recipient of funds obtained
from the Canadian Chemical Producer
Association or the Canadian Chlorine
Coordinating Committee. Funds from these
organizations went to the principal investiga-
tor at Carleton University, and not a penny
was transferred to me. 
I truly believe that the authors of scien-
tific manuscripts should disclose relevant
conflicts of interest, and I support enforcing
disclosure by appropriate means. However,
because Goozner elected to choose the easy
way by conducting an Internet-based
research, without actually talking to me, he
wrongly associated my name with scientific
misconduct. I am presently seeking legal
advice on this matter. 
The author declares he has no competing
financial interests.
Pierre Ayotte 
Public Health Research Unit 
CHUQ-Laval University Medical Center 
Quebec, Canada
E-mail: pierre.ayotte@inspq.qc.ca
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Conflicts of Interest: 
Gulson’s Response
We commend the Center for Science in the
Public Interest (CSPI) for their investiga-
tion into conflicts of interest statements in
leading scientific and medical journals, but
we take exception to our inclusion (Gulson
et al. 2004) as an example of providing mis-
information to EHP.
Goozner’s sweeping statement that my
colleague had previously received research
funding, compensation, or stood to gain
financially from Pasminco Ltd. is highly
inaccurate. We received no research funding,
compensation, or financial gain from the
company to undertake this study. In fact, if
Goozner had read even the abstract of our
article, he would have noted that the find-
ings were detrimental to the company, as
the dominant source of lead in the environ-
ment and children probably derived from
smelter emissions. Furthermore, the smelter
closed in September 2003 and the company
no longer exists. With respect to the associa-
tion of my colleague, Karen Mizon, to her
husband’s company and the (consulting)
work undertaken for Pasminco Ltd., the
work [an International Organization for
Standardization (ISO) Guide 25 accredita-
tion assessment of the company’s on-site lab-
oratory (ISO/International Electrotechnical
Commission 1990)] was undertaken by the
owner for the accreditation body while he
was employed by a federal government
research organization, and he was not paid
for this audit.
The author declares he has no competing
financial interests. 
Brian Gulson
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Macquarie University
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Conflicts of Interest: 
Blumberg’s Response
In his letter, Goozner suggested that I may
have failed to disclose a competing financial
interest in regard to an article published in
EHP. In this article, “Highly Chlorinated
PCBs Inhibit the Human Xenobiotic
Response Mediated by the Steroid and
Xenobiotic Receptor (SXR)” (Tabb et al.
2004), we described differences in how
humans and rodents respond to highly chlo-
rinated polychlorinated biphenyls (PCBs).
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CorrespondenceWe concluded that rodents may not be
appropriate models for exposure to the class
of PCBs discussed in the article and sug-
gested that previous research using rodent
models to predict the effects of these PCBs
on humans may need to be re-evaluated in
light of our findings.
In his letter, Goozner noted that I am
the co-inventor of U.S. Patent 6,391,847
(“Method, polypeptides, nucleotide sequence
of XOR-6, a vitamin D-like receptor from
Xenopus”). This patent describes a frog
nuclear receptor, now referred to as the ben-
zoate “X” receptor (BXR). As I pointed out
on 24 June 2004 in an e-mail message to
Goozner, I am not the owner of this patent;
the patent is owned and controlled by the
Salk Institute for Biological Studies, where I
was employed from 1992 to 1998.
It is difficult to understand how Goozner
reasons that the frog BXR patent is related in
any way to our article on rodent and human
SXR (Tabb et al. 2004). My laboratory
(Grün et al. 2002) and another laboratory
(Moore et al. 2002) have shown that BXR
and SXR (also known as PXR) are function-
ally distinct and that BXRs do not function
as xenobiotic receptors. Therefore, there is
no functional link between BXR and
SXR/PXR, as I also pointed out to Goozner
in my e-mail.
The EHP Instructions to Authors (EHP
2003) defines a competing financial interest
thusly: “Competing financial interests may
include, but are not limited to, grant sup-
port, employment (recent, present, or antici-
pated), and personal financial interests by
the authors, immediate family members, or
institutional affiliations that may gain or
lose financially through publication.”
Therefore, for a competing financial interest
to exist, there must be at least some realistic
probability at the time of submission that
publication of the article in EHP would lead
to financial gain or loss to the authors, their
immediate family members, or institutional
affiliations. Considering that there is no
functional similarity between frog BXR and
rodent and human SXR, it is not reasonable
to infer that publication of the article
regarding the function of SXR in rodents
and humans (Tabb et al. 2004) would have
any influence on financial interests related
to U.S. Patent 6,391,847. Therefore, no
potential competing financial interest
existed at the time of submission or publi-
cation of this manuscript, and as a result,
none was disclosed. 
In view of these ongoing discussions of
interpreting and perhaps heightening the
standards regarding disclosure, I wish to
inform you of a patent that I just learned
was recently issued: U.S. Patent 6,756,491,
“Steroid-activated nuclear receptors and
uses therefore” was issued on 29 June 2004,
over 4 months after the publication of our
article (Tabb et al. 2004) in EHP. I am the
co-inventor of this patent, which teaches
the sequence of SXR and its nucleotide
response elements. Because this patent is
owned and controlled by the Salk Institute,
I was unaware of its status. Had this patent
been issued at the time of submission or
publication of the article (Tabb et al. 2004)
(or had I known that it would issue
shortly), I would have disclosed it as a
potential competing financial interest. In
contrast to the BXR patent, this patent
meets the tests described above. It is func-
tionally connected to the subject matter of
the article, it clearly has commercial value,
and it is foreseeable that I will receive some
fraction of whatever income the Salk
Institute receives in the course of licensing
it to interested parties. Whether or not pub-
lication of the article in EHP will lead to a
financial gain or loss as required by EHP
policy remains to be seen. 
I fully support EHP’s competing finan-
cial interest policy. Goozner argues in his let-
ter to EHP, and in e-mails to me, for a
relatively extreme interpretation of what con-
stitutes a competing financial interest, which,
as far as I understand it, is beyond the scope
of the current EHP policy. Whether such an
interpretation will become the norm for the
scientific community is a matter for future
discussion. Although scientists make a good
faith effort to comply with disclosure
clauses, most are not well trained in under-
standing the legal nuances involved. It
would be very helpful if policies ultimately
adopted by journal editorial boards were
clearly stated and included appropriate
examples so that authors can readily under-
stand the requirements and more effectively
comply with the policy. 
The author is the co-inventor of U.S. Patent
6,756,491, “Steroid-activated nuclear receptors
and uses therefore,” issued on 29 June 2004.
This patent is owned and controlled by the Salk
Institute for Biological Studies, La Jolla,
California, but is likely to generate income to the
inventors as a result of licensing.
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Childhood Leukemia, Military
Aviation Facilities, and
Population Mixing
In a recent article on the striking cluster of
childhood leukemia in 2000–2001 near the
Fallon Naval Air Station in Nevada,
Steinmaus et al. (2004) referred to the
potential relevance of rural–urban popula-
tion mixing. The population-mixing
hypothesis was generated by the observation
of excesses of childhood leukemia in two
remote and isolated areas in Great Britain
that had experienced influxes of significant
numbers of workers as a result of the con-
struction and operation of two large nuclear
facilities (Kinlen 1988). Such mixing will
increase the level of contacts between suscep-
tible (more prevalent in rural areas) and
infected individuals, promoting localized
(frequently subclinical) epidemics of infec-
tions. If childhood leukemia is a rare
response to a common—but unidentified—
infection, then these localized epidemics will
produce excess cases of the unusual compli-
cation, childhood leukemia.
Studies of all known examples of extreme
rural–urban population mixing in Britain in
the past 60 years have, in each instance,
revealed significant temporary excesses of
childhood leukemia (Kinlen 1995, 2000).
These findings have been supported by stud-
ies conducted in other countries, most
recently by an excess of childhood leukemia
in isolated rural counties of the United
States where substantial population increases
have occurred (Wartenberg et al. 2004).
None of these “mixing” situations, how-
ever, can compare in intensity with the
indirect exposure of the small town of
Fallon, Nevada (population 7,536), in only
a few years, to over 100,000 military per-
sonnel from outside the area receiving train-
ing at the naval air station, reaching the
extraordinary level of 55,000 in 2000
(GlobalSecurity.org 2003; U.S. Navy
2002). That the world’s most sharply
defined cluster of childhood leukemia
(Alexander 1993; Steinmaus et al. 2004)
should occur in association with the most
extreme example of rural–urban population
mixing could not be more arresting (Kinlen
and Doll 2004). 
Every opportunity should be taken to
investigate the role that infection may have
played in this extraordinary cluster of child-
hood leukemia. Unlike most studies of
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evant circumstances occurred some time
ago, this recent cluster provides researchers
with the chance to thoroughly study the
cases (and other members of the popula-
tion) for evidence of exposure to the rele-
vant infectious agent. It is an opportunity
that should not be missed. 
The author declares he has no competing
financial interests.
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Editor’s note: In accordance with jour-
nal policy, Steinmaus et al. were asked
whether they wanted to respond to this letter,
but they chose not to do so.
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